Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

J Cancer 2018; 9(2):433-439. doi:10.7150/jca.21465 This issue Cite

Research Paper

Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis

Yang Yang, Danhong Zhang, Xia Zhou, Wuan Bao, Yonglin Ji, Liming Sheng, Lei Cheng, Ying Chen, Xianghui Du, Guoqin Qiu✉

Department of Radiation Therapy, Zhejiang Cancer Hospital, Hangzhou, China; Zhejiang Key Laboratory of Radiation Oncology, Hangzhou 310022, China.

✉ Corresponding author: Guoqin Qiu, Department of Radiation Therapy, Zhejiang Cancer Hospital, Hangzhou, China; Zhejiang Key Laboratory of Radiation Oncology, NO. 38 of Guang ji Road, Hangzhou 310022, China. Tel: +86-571-88128182; Email: qiuguoqinzjcc More

Citation:
Yang Y, Zhang D, Zhou X, Bao W, Ji Y, Sheng L, Cheng L, Chen Y, Du X, Qiu G. Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis. J Cancer 2018; 9(2):433-439. doi:10.7150/jca.21465. https://www.jcancer.org/v09p0433.htm
Other styles

File import instruction

Abstract

Background: The use of PCI in early operable patients with small cell lung cancer (SCLC) is still controversial. Therefore, we conducted a systematic review with meta-analysis to investigate the effects of PCI in resected SCLC patients.

Methods: Relevant studies were identified from PubMed and EMBASE databases, the pooled hazard risks were obtained by the random-effects model. We also analyzed the brain metastasis (BM) risk in p-stage I patients without PCI.

Results: Five retrospective studies were identified and a total of 1691 patients were included in our analysis, 315 of them received PCI. For all the resected patients, PCI was associated with improved overall survival (HR: 0.52, 95% CI: 0.33-0.82), and reduced brain metastasis risk (RR: 0.50, 95%CI: 0.32-0.78). However, with regard to p-stage I patients, no survival benefit was brought by PCI (HR: 0.87, 95% CI: 0.34-2.24). Moreover, the pooled analysis of 7 studies found that the 5-year brain metastasis risk was relatively low (12%, 95% CI: 8%-17%) for p-stage I patients without PCI.

Conclusions: PCI might be associated with a favorable survival advantage and reduced BM risk in complete resected SCLC patients, except for p-stage I patients.

Keywords: small cell lung cancer, surgery, PCI, radiotherapy, meta-analysis

Citation styles

APA
Yang, Y., Zhang, D., Zhou, X., Bao, W., Ji, Y., Sheng, L., Cheng, L., Chen, Y., Du, X., Qiu, G. (2018). Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis. Journal of Cancer, 9(2), 433-439. https://doi.org/10.7150/jca.21465.

ACS
Yang, Y.; Zhang, D.; Zhou, X.; Bao, W.; Ji, Y.; Sheng, L.; Cheng, L.; Chen, Y.; Du, X.; Qiu, G. Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis. J. Cancer 2018, 9 (2), 433-439. DOI: 10.7150/jca.21465.

NLM
Yang Y, Zhang D, Zhou X, Bao W, Ji Y, Sheng L, Cheng L, Chen Y, Du X, Qiu G. Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis. J Cancer 2018; 9(2):433-439. doi:10.7150/jca.21465. https://www.jcancer.org/v09p0433.htm

CSE
Yang Y, Zhang D, Zhou X, Bao W, Ji Y, Sheng L, Cheng L, Chen Y, Du X, Qiu G. 2018. Prophylactic cranial irradiation in resected small cell lung cancer: A systematic review with meta-analysis. J Cancer. 9(2):433-439.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use